Pharmaceutical companies are constantly adapting and evolving their systems to keep up with new regulatory requirements. But modernization isn’t always easy, and it must be done without disrupting quality, efficiency, and most importantly, compliance. In a highly regulated industry like pharma, it’s essential to carefully plan each change.  There is a delicate balance between enhancing […]

As health authorities around the world move steadily toward structured labeling standards like electronic Product Information (ePI), Pharma Ledger, and Structured Product Monograph (SPM), mid-to-large-sized pharmaceutical companies are asking a critical question: How do we support global requirements without overextending our internal teams or making irreversible investments? For many, the answer is to partner with […]

Pharmaceutical organizations, whether global giants or mid-sized companies, are facing a regulatory wave. With the Jordan Food and Drug Administration (JFDA) mandating the submission of electronic product information (ePI) in the Fast Healthcare Interoperability Resources (FHIR) format, the European Medicine Agency (EMA) wrapping up its successful FHIR pilot program, and a growing number of countries […]